Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer

MLA

Guardiola, E., et al. “Results of a Randomised Phase II Study Comparing Docetaxel with Methotrexate in Patients with Recurrent Head and Neck Cancer.” European Journal of Cancer, vol. 40, no. 14, Sept. 2004, pp. 2071–76. EBSCOhost, https://doi.org/10.1016/j.ejca.2004.05.019.

APA

Guardiola, E., Peyrade, F., Chaigneau, L., Cupissol, D., Tchiknavorian, X., Bompas, E., Madroszyk, A., Ronchin, P., Schneider, M., Bleuze, J. P., Blay, J. Y., & Pivot, X. (2004). Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer. European Journal of Cancer, 40(14), 2071–2076. https://doi.org/10.1016/j.ejca.2004.05.019

Chicago

Guardiola, E., F. Peyrade, L. Chaigneau, D. Cupissol, X. Tchiknavorian, E. Bompas, A. Madroszyk, et al. 2004. “Results of a Randomised Phase II Study Comparing Docetaxel with Methotrexate in Patients with Recurrent Head and Neck Cancer.” European Journal of Cancer 40 (14): 2071–76. doi:10.1016/j.ejca.2004.05.019.